 |
|
February 23, 2009 | |
CASE CCC IN THE NEWSCancer death rates among blacks down, but not all news good ... Northeast Ohio Health and Medical Consumer News Scientists ready to jump-start embryonic stem-cell research NIH awards Case Western Reserve University $1.33M THE STIMULUS PACKAGE AND NIH- Excerpts From an Announcement Made by Raynard S. Kington, MD, PhD, Acting Director, NIHOn Tuesday, February 17, 2009, President Barack Obama signed the American Recovery & Reinvestment Act of 2009 (ARRA), the economic stimulus, into law... The stimulus bill provides a total of $10.4 billion, all available for two years--through September 2010. We expect to spend as much as possible in FY 2009 to support the goals of the ARRA and advance scientific priorities. (Note that none of these resources are added to the NIH's future base funding level). Below is a summary: $8.2 billion in support of scientific research priorities $1 billion to support Extramural Construction, Repairs, and Alterations $500 million for NIH buildings and facilities
Many types of funding mechanisms will be supported, but, in general, NIH will focus scientific activities in several areas:
The impact of this stimulus to scientists cannot be overstated. The impact extends far beyond the current economic challenges and immediate scientists who will receive funds, to allied health workers, technicians, students, trade workers and others who will receive the leveraged benefits. We understand to accomplish the goals of ARRA, it will take the help of the entire scientific community. Beyond the immediate economic stimulus, the long-term impact from the science funded by the ARRA will have a positive impact upon the health of the nation for years to come. The ARRA is complex, with multi-layered reporting requirements. NIH is working with the Administration to ensure transparency and accountability. In the near future, NIH will post information about its role in the recovery and impact on RECOVERY.gov. We are committed, with the outstanding support that has been given by the White House, the Department, and Congress, to make our decisions based on best scientific opportunity and public need. We will seek projects with the broadest impact, work that can be accomplished in two years, that relies heavily on our new streamlined, modernized peer review system. This is not a time for business as usual nor formulaic solutions; this is a time for true innovation, energy, and recovery. To view the entire message from Dr. Kington, please click here. MARK YOUR CALENDARS– Case Scientific Series: Transcriptional Regulatory Networks in Breast CancerPlease mark your calendars for the next installment of the Case CCC Scientific Series, Transcriptional Regulatory Networks in Breast Cancer. Drs. Ruth Keri, Monica Montano, Noa Noy, Mukesh Jain, and Julian Kim will present on their pilot projects, which were funded by the Breast Cancer Working Group. This event is scheduled for Tuesday, March 24 in Wolstein Auditorium; the program will begin at 4:00 pm, with a reception immediately following. All are encouraged to attend. MARK YOUR CALENDARS– 11th Annual Midwest DNA Repair SymposiumMay 16-17, 2009 Please mark your calendars for the 11th Annual Midwest DNA Repair Symposium, which will be held on May 16-17, 2009 at the University of Michigan. The tradition of these symposia has always been to make them affordable, promote presentations by students and young investigators, and to stimulate interactions between DNA repair labs in the Midwest. Topics to be covered include: DNA repair enzymology, DNA damage signaling, DNA repair and chromatin, transcription and replication "stress", DNA repair in stem cells, and DNA repair as a therapeutic target. The abstract submission deadline is May 1. Students and postdocs are encouraged to present. For details, please click here. MARK YOUR CALENDARS– Neuropathic Cancer Pain SymposiumApril 27, 2009 The National Cancer Institute and the NIH Pain Consortium will host a Neuropathic Cancer Pain Symposium, which will bring together a multi-disciplinary group of researchers, clinicians, and patient advocates to build upon our knowledge and understanding of the role of pain and pain management in cancer care. This symposium seeks to address the knowledge gap in the area of neuropathic pain associated with cancer, due to the underlying disease, as well as therapy. Planners aim to develop a symposium report, a synopsis of which could be published in a peer-review journal as a call-to-action to government, industry, clinicians, and others. The symposium will include plenary sessions, panel discussions, and opportunities for networking. Participants will explore several focus areas, including: For details, please click here. FUNDING OPPORTUNITY– Paul Marks Prize for Cancer ResearchMemorial Sloan Kettering Cancer Center is accepting applications for the Paul Marks Prize for Cancer Research. This award recognizes outstanding young investigators who have made significant contributions to increase the understanding of cancer or improve the treatment of the disease through basic or clinical research. The Paul Marks Prize is now awarded to up to three investigators every other year. The first recipients were named in 2001. The winners will present their work at a scientific symposium at Memorial Sloan-Kettering Cancer Center on December 3, 2009. They will share a cash award of $150,000. Nominations must be received by April 30 For more information, please click here. |
EVENTS**All events are open to anyone interested in attending February 23Hematology/Oncology Research In Progress Seminar Pathology Research Seminar Pediatric Hematology/Oncology Guest Lecture Physiology & Biophysics Seminar February 24Taussig Cancer Institute Core Curriculum Series February 25Grand Rounds Immunology Seminar Pathology Graduate Student Seminar February 26Neurosciences Seminar TREC Seminar Taussig Cancer Institute Core Curriculum Series February 27Hematology/ Oncology Fellows Seminar cancelled Pathology Faculty Candidate Seminar Taussig Cancer Institute Grand Rounds Cancer Center Seminar Series/ Blood Club Cancer Prevention and Control Seminar more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMSCase CCC Scientific Series Family-Centered Care Signaling in Cancer Ohio Collaborative Conference on Bioinformatics (OCCBIO) Annual Breast Cancer Update: Highlights of the National Meetings Case CCC Scientific Retreat 2009 **For more information on these symposiums, please contact Christine Rhoads. UPCOMING OUTSIDE SEMINARS2nd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science Second Annual David C. Hohn, MD Health Policy Lecture |
FUNDING OPPORTUNITY– ASH Trainee Research AwardThe American Society of Hematology (ASH) is accepting applications for the 2009 ASH Trainee Research Award. This award provides support for medical students, residents, and undergraduates for a three-month hematology-related research project and travel to the ASH annual meeting. This experience will expose the participants to hematology research early in their career and hopefully encourage them to continue research as a part of their future training. Deadline: March 16 For more information, please click here. FUNDING OPPORTUNITY– American Cancer Society IRG AwardsThe Case CCC is accepting applications for American Cancer Society (ACS) IRG pilot funding for cancer-related research in basic, clinical, prevention & control, behavioral, health services and epidemiology. These pilot project grants are intended to support independent, self-directed investigators early in their careers (usually assistant professor or equivalent). Applicants for the pilot project grants should be within six years of their first independent research or faculty appointment and eligible to apply for independent national competitive research grants, but may not currently hold such a grant. Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application. Application Deadline: April 6 Instructions, frequently asked questions, and applications available at http://cancer.case.edu. Contact Terri Daso, Cancer Center Administration, 844-7252, tld6@case.edu for more information. FUNDING OPPORTUNITY– Association for International Cancer Research (AICR)AICR awards project grants of between one and three years to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. We will consider proposals in which a mixture of basic and clinical research is proposed. However, completely clinical applications, such as intervention studies, clinical trials or health care delivery research and many substantially clinical applications are beyond the remit of AICR. Before submitting applications of a clinical or semi-clinical nature, potential applicants are strongly encouraged to seek our advice by e-mailing a brief description of the proposed project to our Scientific Co-ordinator (matfield@aicr.org.uk). Applications will be accepted April 1-24. For details, please click here. FUNDING OPPORTUNITY– Choose Ohio First Scholarship and Tomas – Evelyn James Fellowship in Bioinformatics, Computational Biology and Medical InformaticsThe primary objective of the Choose Ohio First Scholarship (COF) Program is to support increased higher education participation and success of Ohio students in bioinformatics, computational biology and medical informatics, through the development and implementation of innovative curricular and programs, and in so doing, to advance the economic growth of the state. Bioinformatics, computational biology, imaging, clinical and translational informatics, cancer informatics are commonly cast as sub-domains within Biomedical Informatics, the broad discipline concerned with the study and application of computer science, information science, informatics, cognitive science and human-computer interaction in the practice of biological research, biomedical science, medicine and healthcare. The deadline has been extended to February 27. For details, please click here. CSCRM NEWSThe CSCRM would like to draw your attention to some WaferGen microscope stage size hypoxia units, which may be useful in your research. WaferGen is willing to come to Cleveland and provide a demonstration provided there is sufficient investigator interest. If you are interested, please contact Susan Halloway. Please click on the following links for more information: FUNDING OPPORTUNITY– Dana Foundation Program in Neuroimmunology of Brain Infections and CancersCWRU SOM has been invited to nominate ONE applicant for the Dana Foundation Program in Neuroimmunology of Brain Infections and Cancers. The Neuroimmunology Program was redesigned to focus on brain infections and cancers. The Foundation is inviting studies of 1) immune-based therapies for primary brain tumors and for metastases to the brain of other cancers; 2) immune responses to infections in the brain including but not limited to viral encephalitis, meningitis, cerebral malaria, and prion diseases; and 3) how immune functions are carried out and modified in the brain. The program focuses on clinical studies in humans or human tissues. Animal studies that are directly relevant to human disease but not ready for application to studies of humans or human tissues will also be considered. This award is open to faculty tenure track researchers early in their career at the assistant professor level or early in their associate professor career. Established researchers pioneering efforts in brain infections and cancers are also eligible to apply. Postdoctoral fellows are not eligible. Projects involving collaborations with NIH intramural researchers or industry scientists are acceptable. Proposals for research that can be supported through clinical income should not be submitted. Internal Deadline: March 2 For more information, please click here. Please contact Richard J. Sohn, PhD, Richard.Sohn@case.edu., (216)368-1158 with any questions. FUNDING OPPORTUNITY– James S. McDonnell FoundationThe Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems. In each case the focus of the collaborative activity must meet the program guidelines for one of the following program areas: Applications are continuously accepted for these awards. For more information, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESNational Science Foundation Partnerships for International Research and Education (PIRE) |
NIH Bulletin – Notices and Funding OpportunitiesTesting Tobacco Products Promoted to Reduce Harm (R01) (PA-09-046) Testing Tobacco Products Promoted to Reduce Harm (R21) (PA-09-047) |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Hassinger 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.hassinger@uhhospitals.org |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |